GSK, Moderna Settle Patent Dispute Over Moderna COVID, RSV Vaccines
Nov 6, 2026
GSK and Moderna settled patent litigation regarding their COVID-19 and RSV vaccines, granting cross-licenses without payment obligations. Both parties dismissed US infringement claims to facilitate continued innovation in infectious disease therapeutics.